+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Reckitt Benckiser Group

(OTCPK:RBGPF)

Intraday

$55.134

0.264[0.48%]

Perks Buy Compare Brokers

$55.134

0.264[0.48%]

At close: May 1

Overview News Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest News for Reckitt Benckiser Group Stock (OTC:RBGPF)

Reckitt Benckiser Group Stock (OTC: RBGPF)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, March 15, 2024

What's Going On With Abbott Laboratories Stock On Friday?
Vandana Singh - Mar 15, 2024, 1:48PM

Thursday, February 29, 2024

Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
Benzinga Neuro - Feb 29, 2024, 2:54AM

Tuesday, September 12, 2023

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
Vandana Singh - Sep 12, 2023, 4:06PM

Wednesday, May 24, 2023

Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
Vandana Singh - May 24, 2023, 8:39AM

Friday, December 02, 2022

Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Anusuya Lahiri - Dec 2, 2022, 6:53AM

Thursday, September 01, 2022

Dettol Maker Reckitt Benckiser's CEO Steps Down
Shivani Kumaresan - Sep 1, 2022, 7:58AM

Thursday, August 11, 2022

Baby Formula Startup Seeks To Compete Abbott With 15% Market Share: Report
Vandana Singh - Aug 11, 2022, 7:40AM

Wednesday, July 27, 2022

Reckitt Lifts Annual Forecast On Higher Prices, Baby Formula Shortage
Vandana Singh - Jul 27, 2022, 7:37AM

Wednesday, May 25, 2022

More Companies Join Race To Ease US Baby Formula Supply Crunch
Vandana Singh - May 25, 2022, 7:26AM

Friday, May 20, 2022

Danone Scales Up Baby Formula Shipments To US To Combat Shortage: Reuters
Vandana Singh - May 20, 2022, 7:47AM

Friday, April 29, 2022

Morning Brief: Top Financial Stories Dominating on Friday, April 29
Akanksha Bakshi - Apr 29, 2022, 7:52AM
Reckitt Benckiser Hikes Prices To Compensate For Falling Demand: FT
Shivani Kumaresan - Apr 29, 2022, 7:37AM

Thursday, October 26, 2017

Wall Street's M&A Chatter From October 25: Sprint-T-Mobile, Trade Desk, Pfizer, Dynegy
Benzinga - Oct 26, 2017, 7:35AM

Monday, July 17, 2017

Wall Street's M&A Chatter From July 14-16: Dominion Diamond, Unilever-Hormel-Reckitt, H&E Equipment-Neff, Mobileye-Intel
Benzinga - Jul 17, 2017, 7:02AM

Thursday, May 01, 2014

Benzinga's M&A Chatter for Thursday May 1, 2014
Benzinga - May 1, 2014, 6:51PM

Wednesday, April 30, 2014

Reckitt Benckiser Confirms it is No Longer in Talks with Merck Regarding Bid for Consumer Health Business
Benzinga - Apr 30, 2014, 12:54PM

Monday, April 28, 2014

Benzinga's M&A Chatter for Monday April 28, 2014
Benzinga - Apr 28, 2014, 6:50PM
Reckitt Benckiser Confirms Talks With Merck Regarding Bid for Consumer Health Business, Bayer Also Rumored Bidder
Benzinga - Apr 28, 2014, 12:11PM

Sunday, April 27, 2014

Benzinga's Weekend M&A Chatter
Benzinga - Apr 27, 2014, 8:21PM

Saturday, April 26, 2014

Reuters Reports Merck in Talks to Sell Consumer Health Unit to Bayer, Reckitt Benckiser for Approximately $14B, According to Sources
Benzinga - Apr 26, 2014, 2:41PM

Friday, November 22, 2013

Reuters Reports Reckitt Benckiser Hires Morgan Stanley to Advise on Options for Pharma Unit
Benzinga - Nov 22, 2013, 1:29PM

Wednesday, September 11, 2013

Reckitt Benckiser CEO Rakesh Kapoor Says Company has Ability to do Large M&A -Reuters
Benzinga - Sep 11, 2013, 10:30AM

Monday, August 05, 2013

Is Procter & Gamble a Strategic Bet?
Benzinga - Aug 5, 2013, 9:16AM

Thursday, November 22, 2012

Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga - Nov 22, 2012, 12:06PM

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved